Psiac

Literaturverzeichnis


Ulrich S. Int J Clin Pharmacol Ther. Jan 2003; 41(1): 3-13 Pubmed [1192]
Unadkat, Chien. Pharm Res (1988)5 (Suppl), S177 [1795]
Unglaub et al. (2002) Psychiatr Prax 30: Suppl. 2: S121-124 [1163]
Unglaub et al. (2003) Psychiatr Prax 30 (Suppl. 2): S121-S124 [1149]
Unholzer S. Pharmacopsychiatry. Sep 2015; 48(6): 211-4 Pubmed [743]
Unterecker S. Int Clin Psychopharmacol. Jul 2014; 29(4): 206-11 Pubmed, Volltext, DOI [3077]
Unterecker S. J Clin Psychopharmacol. Aug 2013; 33(4): 561-4 Pubmed [4698]
Uprima (Apomorphine). Abott Laboratories Ltd. Summary of Product Characteristics, May 2001 [1960]
Uprima (Apomorphine). Abott Laboratories Ltd. Summary of Product Charakteristics, May 2001 [833]
Urban AE. Psychiatr Danub. Sep 2015; 27 Suppl 1: S459-61 Pubmed [1142]
Urbanek C, Jockers-Scherübl MC, Vorsicht Pflanze!, NEUROTRANSMITTER 4/2006: 87-88 [3344]
Urbano & Ware (2008) J Clin Psychopharmacol 28:704-705 [2235]
US-Prescribing information for FIRMAGON® [3874]
Usiskin SI. Am J Psychiatry. Jun 2000; 157(6): 1021 Pubmed [1114]
Uttamsingh V. Drug Metab Dispos. Nov 2005; 33(11): 1723-8 Pubmed [290]
Vadlapatla RK. Expert Opin Drug Metab Toxicol. Apr 2014; 10(4): 561-80 Pubmed, Volltext, DOI [4005]
Vainer JL, Chouinard G. Caffeine and antipsychotics. Clin Invest Med (1993) 16 (Suppl 4), B20 [1097]
Vainer JL. J Clin Psychopharmacol. Aug 1994; 14(4): 284-5 Pubmed [1094]
Vakkalagadda et al. Am J Cardiovasc Drugs. 2016 Jan 9 [4138]
Vale JA. Lancet. Jun 1991; 337(8756): 1552 Pubmed [1279]
Vallejo R. Pain Physician. Jul 2011; 14(4): E343-60 Pubmed [3301]
van de Wetering-Krebbers SF. Drug Metab Dispos. Apr 2011; 39(4): 580-90 Pubmed [250]
van den Berg MJ. Am J Ther. Jan 2016; 23(1): e246-8 Pubmed [1592]
van der Kuy PH. BMJ. Feb 1998; 316(7129): 441 Pubmed, Volltext [1954]
van der Weide K. J Clin Psychopharmacol. Jun 2015; 35(3): 228-36 Pubmed [193]
van Giersbergen PL. Clin Pharmacol Ther. Mar 2007; 81(3): 414-9 Pubmed [4289]
van Giersbergen PL. Int J Clin Pharmacol Ther. Mar 2006; 44(3): 113-8 Pubmed [4287]
van Harten et al. Eur Neuropsychopharmacol (1992) 2, 381 [1462]
van Harten J. Clin Pharmacokinet. Jan 1995; 29 Suppl 1: 1-9 Pubmed [325]
van Harten J. Clin Pharmacol Ther. Oct 1992; 52(4): 427-35 Pubmed [1457]
van Heeswijk RP. J Clin Pharmacol. Jul 2006; 46(7): 758-67 Pubmed [461]
Van Kammen DP. Psychopharmacologia. Nov 1975; 44(3): 215-24 Pubmed [1743]
van Luin M. J Clin Pharmacol. Oct 2009; 49(10): 1220-7 Pubmed [2953]
Van Strater AC. Int Clin Psychopharmacol. Mar 2012; 27(2): 121-4 Pubmed [1129]
van Wieringen A. Clin Pharmacokinet. Apr 1990; 18(4): 332-8 Pubmed [2451]
van Zwieten PA. Arch Int Pharmacodyn Ther. Mar 1975; 214(1): 12-30 Pubmed [1941]
Vanakoski J. Eur J Clin Pharmacol. Jan 1996; 50(6): 501-8 Pubmed [1877]
Vandel et al. Pharm Res 1995;31(6):347-353 [1025]
Vandel et al. Therapie (1990) 45, 21 [1027]
Vandel P. Encephale. Jan 1999; 25(1): 67-71 Pubmed [3182]
Vandel S. Pharmacol Res. Jun 1995; 31(6): 347-53 Pubmed [1480]
Vandel S. Ther Drug Monit. Jan 1988; 10(4): 386-9 Pubmed [2421]
Vandel. Therapie (1990) 45, 21 [544]
VandenBrink BM. Drug Metab Dispos. Jan 2012; 40(1): 47-53 Pubmed [3488]
Varhe A. Br J Clin Pharmacol. Apr 1996; 41(4): 319-23 Pubmed, Volltext, DOI [2398]
Varhe A. Br J Clin Pharmacol. Oct 1996; 42(4): 465-70 Pubmed, Volltext, DOI [2394]
Varhe A. Clin Pharmacol Ther. Apr 1996; 59(4): 369-75 Pubmed [2400]
Varhe A. Clin Pharmacol Ther. Dec 1994; 56(6 Pt 1): 601-7 Pubmed [2396]
Varis et al. Clin Pharmacol Therap 2000;68(5):487-494 [2972]
Varis T. Clin Pharmacol Ther. Nov 2000; 68(5): 487-94 Pubmed [4493]
Varsaldi F. Eur J Clin Pharmacol. Sep 2006; 62(9): 721-6 Pubmed [113]
Vasquez E. Clin Transplant. Apr 2001; 15(2): 95-9 Pubmed [3089]
Vautier S. Eur J Pharm Sci. Feb 2006; 27(2-3): 167-74 Pubmed [58]
Vaz J et al.,Indian J Clin Pharmacol (1998) 45, 176-8 [2429]
Vella JP. Am J Kidney Dis. Feb 1998; 31(2): 320-3 Pubmed [1466]
Vella T. J Pharm Pharmacol. Jun 2014; 66(6): 747-59 Pubmed [1977]
Venkatakrishnan K. Drug Metab Dispos. Jun 2005; 33(6): 845-52 Pubmed [1232]
Venkatakrishnan K. J Clin Pharmacol. Feb 1998; 38(2): 112-21 Pubmed [38]
Venkatakrishnan K. J Clin Pharmacol. Oct 2001; 41(10): 1043-54 Pubmed [4230]
Ventafridda et al. Lancet (1987) i, 1204 [1032]
Vermeir M. Drug Metab Dispos. Apr 2008; 36(4): 769-79 Pubmed [245]
Vermeir M. Drug Metab Dispos. Apr 2009; 37(4): 809-20 Pubmed [4217]
Vermes A. Am J Cardiovasc Drugs. Jan 2004; 4(4): 247-55 Pubmed [205]
Vernon C. Br J Clin Pract. Apr 1979; 33(4): 112, 121 Pubmed [3266]
Veronese ML. J Clin Pharmacol. Aug 2003; 43(8): 831-9 Pubmed [1878]
Verpooten GA. Br J Clin Pharmacol. Aug 1991; 32(2): 187-92 Pubmed, Volltext [4264]
Verrando R. Acta Gastroenterol Belg. Jan 2005; 68(1): 81-5 Pubmed [3459]
Veselinović T. Psychopharmacology (Berl). May 2015; 232(9): 1607-17 Pubmed [4338]
Vestal RE, Kornhauser DM, Hollifierld JW, Shand DG. Inhibition of propanolol metabolism by chlorpromazine. Clin pharmacol Ther (1979) 25, 19-25 [922]
Vestri et al. (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacol 32:765-772 [2783]
Vetter PH, Proppe DG. Clozapine induced coma. J Nerv Ment Dis (1992) 180, 58-9 [1052]
Vevelstad M. Eur J Clin Pharmacol. Aug 2009; 65(8): 795-801 Pubmed [405]
vgl. auch Literatur zur Interaktion von Clozapin mit Benzodiazepinen [1963]
Vickers AE. Drug Metab Dispos. Sep 1999; 27(9): 1029-38 Pubmed [213]
Vidal X. Drug Saf. Jan 2008; 31(2): 159-68 Pubmed [998]
Vieta E. J Affect Disord. Aug 2008; 109(3): 251-63 Pubmed [3891]
Vieweg WV. Drugs Aging. Jan 2009; 26(12): 997-1012 Pubmed [2631]
Vigneault P. Eur J Pharmacol. Apr 2012; 681(1-3): 68-74 Pubmed [3968]
Vigneault P. J Cardiovasc Pharmacol. Jun 2011; 57(6): 690-5 Pubmed [2630]
Vihavainen T. J Neurochem. Nov 2008; 107(3): 844-54 Pubmed [4167]
Villikka K. Clin Pharmacol Ther. Dec 1999; 66(6): 589-93 Pubmed [781]
Vinceneux P. Int J Clin Pharmacol Ther Toxicol. Mar 1986; 24(3): 153-8 Pubmed [3569]
Vincent FM. Ann Intern Med. Jul 1980; 93(1): 56-7 Pubmed [652]
Vincent J. Br J Clin Pharmacol. Nov 2000; 50(5): 455-63 Pubmed, Volltext, DOI [3815]
Vincent SH. Drug Metab Dispos. Apr 2007; 35(4): 533-8 Pubmed [4324]
Vitali M. J Clin Psychopharmacol. Feb 2013; 33(1): 95-8 Pubmed [4874]
Vobra SB. Convulsions after enflurane in a schizophrenic patient receiving neuroleptics. Can J Anaesth (1994) 41, 420-2 [864]
Vogelman et al. Neuropsychopharmacol 1999;20:480-490 [3135]
Voican CS. Am J Psychiatry. Apr 2014; 171(4): 404-15 Pubmed [3898]
Volans A. BMJ Case Rep. Jan 2013; 2013 Pubmed, Volltext, DOI [4033]
Voll ML. Pharm World Sci. Oct 2010; 32(5): 575-80 Pubmed [3671]
Volpi-Abadie J. Ochsner J. Jan 2013; 13(4): 533-40 Pubmed, Volltext [18]
von Moltke et al. J Pharm Sci. 1998 Oct;87(10):1184-9 [1234]
von Moltke LL. Biol Psychiatry. Feb 1997; 41(3): 377-80 Pubmed [3738]
von Moltke LL. Br J Clin Pharmacol. Jul 1994; 38(1): 23-31 Pubmed, Volltext [1331]
Von Moltke LL. Br J Clin Pharmacol. Jul 1999; 48(1): 89-97 Pubmed, Volltext, DOI [234]
von Moltke LL. Drug Metab Dispos. Aug 2001; 29(8): 1102-9 Pubmed [118]
von Moltke LL. J Clin Pharmacol. Dec 1994; 34(12): 1222-7 Pubmed [1881]
von Moltke LL. J Clin Pharmacol. Jan 2001; 41(1): 85-91 Pubmed [4636]
von Moltke LL. J Clin Pharmacol. Sep 1996; 36(9): 783-91 Pubmed [1874]